NEUROCRINE BIOSCIENCES INC (NBIX)
US64125C1099 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.134B 8.38% | 1.489B 31.34% | 1.887B 26.76% | 2.398B 27.07% | 2.796B 16.60% | 3.267B 16.85% | 3.71B 13.56% | 4.141B 11.62% | 4.328B 4.52% | 4.595B 6.17% | 4.859B 5.75% | |
| EBITDA YoY % growth | 218.7M -34.93% | 266.3M 21.76% | 416.1M 56.25% | 707.32M 69.99% | 815.34M 15.27% | 1.152B 41.29% | 1.386B 20.31% | 1.77B 27.71% | 2.414B 36.38% | 2.694B 11.60% | N/A | |
| EBIT YoY % growth | 207.8M -36.55% | 250.7M 20.64% | 394.8M 57.48% | 621.16M 57.34% | 780.64M 25.67% | 1.148B 47.06% | 1.426B 24.22% | 1.768B 23.98% | 1.823B 3.11% | 1.95B 6.97% | 2.232B 14.46% | |
| Operating Margin | 18.33% | 16.84% | 20.92% | 25.90% | 27.92% | 35.14% | 38.44% | 42.70% | 42.12% | 42.44% | 45.94% | |
| EPS YoY % growth | 1.32 1.54% | 1.53 15.91% | 2.42 58.17% | 4.20 73.49% | 6.21 47.97% | 8.81 41.83% | 13.10 48.70% | 15.49 18.24% | 16.58 7.02% | 17.71 6.84% | 17.99 1.58% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.67 16.06% | 1.35 222.19% | 1.47 133.05% | 1.59 28.46% | 1.88 12.23% | 2.13 57.54% | 2.44 66.04% | 2.59 62.65% | 2.79 49.00% |
| Revenue Q2Q % growth | 641.44M 24.50% | 636.68M 23.56% | 684.14M 15.92% | 718.04M 15.42% | 753.54M 17.48% | 814.86M 27.99% | 853.49M 24.75% | 885.88M 23.37% | 917.45M 21.75% |
| EBITDA Q2Q % growth | 224.02M 30.55% | 198.09M 77.66% | 215.36M 33.43% | 211.35M 3.20% | 264.75M 18.18% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 206.3M 37.26% | 172.27M 63.60% | 190.04M 28.49% | 204.4M 10.61% | 244.69M 18.61% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.24 51.22% | 1.50 | -0.26 | -17.35% |
| Q2 2024 Q2Q % growth | 0.63 -33.68% | 1.08 | -0.45 | -41.42% |
| Q1 2024 Q2Q % growth | 0.42 153.16% | 1.03 | -0.61 | -59.17% |
| Q4 2023 Q2Q % growth | 1.44 63.64% | 1.17 | 0.27 | 23.28% |
| Q3 2023 Q2Q % growth | 0.82 18.84% | 0.99 | -0.17 | -16.79% |
| Q2 2023 Q2Q % growth | 0.95 627.78% | 0.79 | 0.16 | 19.84% |
| Q1 2023 Q2Q % growth | -0.79 -664.29% | 0.13 | -0.92 | -697.25% |
| Q4 2022 Q2Q % growth | 0.88 1,200.00% | 1.18 | -0.30 | -25.33% |
| Q3 2022 Q2Q % growth | 0.69 7.81% | 0.81 | -0.12 | -14.90% |
| Q2 2022 Q2Q % growth | -0.18 -141.86% | 0.61 | -0.79 | -129.58% |
| Q1 2022 Q2Q % growth | 0.14 -57.58% | 0.36 | -0.22 | -60.95% |
| Q4 2021 Q2Q % growth | -0.08 -111.11% | 0.53 | -0.61 | -115.18% |
| Q3 2021 Q2Q % growth | 0.64 203.23% | 0.62 | 0.02 | 3.97% |
| Q2 2021 Q2Q % growth | 0.43 -46.91% | 0.49 | -0.06 | -12.38% |
| Q1 2021 Q2Q % growth | 0.33 -15.38% | 0.52 | -0.19 | -36.84% |
| Q4 2020 Q2Q % growth | 0.72 105.71% | 0.55 | 0.17 | 31.63% |
| Q3 2020 Q2Q % growth | -0.62 -210.71% | 0.17 | -0.79 | -456.57% |
| Q2 2020 Q2Q % growth | 0.81 50.00% | 0.75 | 0.06 | 8.08% |
| Q1 2020 Q2Q % growth | 0.39 134.82% | 0.55 | -0.16 | -29.31% |
| Q4 2019 Q2Q % growth | 0.35 84.21% | 0.77 | -0.42 | -54.31% |
| Q3 2019 Q2Q % growth | 0.56 7.69% | 0.65 | -0.09 | -13.98% |
| Q2 2019 Q2Q % growth | 0.54 871.43% | 0.11 | 0.43 | 396.12% |
| Q1 2019 Q2Q % growth | -1.12 -138.30% | -0.94 | -0.18 | -18.75% |
| Q4 2018 Q2Q % growth | 0.19 | 0.19 | 0.00 | 1.97% |
| Q3 2018 Q2Q % growth | 0.52 | 0.47 | 0.05 | 11.43% |
| Q2 2018 Q2Q % growth | -0.07 | -0.17 | 0.10 | 59.10% |
| Q1 2018 Q2Q % growth | -0.47 | -0.31 | -0.16 | -52.07% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 622.1M 24.72% | 612.64M | 9.46M | 1.54% |
| Q2 2024 Q2Q % growth | 590.2M 30.37% | 556.86M | 33.34M | 5.99% |
| Q1 2024 Q2Q % growth | 515.3M 22.57% | 522.21M | -6.91M | -1.32% |
| Q4 2023 Q2Q % growth | 515.2M 25.05% | 528.84M | -13.64M | -2.58% |
| Q3 2023 Q2Q % growth | 498.8M 28.59% | 479.9M | 18.9M | 3.94% |
| Q2 2023 Q2Q % growth | 452.7M 19.70% | 456.25M | -3.55M | -0.78% |
| Q1 2023 Q2Q % growth | 420.4M 35.35% | 417.45M | 2.95M | 0.71% |
| Q4 2022 Q2Q % growth | 412M 32.05% | 417.05M | -5.05M | -1.21% |
| Q3 2022 Q2Q % growth | 387.9M 31.05% | 384.51M | 3.39M | 0.88% |
| Q2 2022 Q2Q % growth | 378.2M 30.91% | 348.13M | 30.07M | 8.64% |
| Q1 2022 Q2Q % growth | 310.6M 31.28% | 310.27M | 330K | 0.11% |
| Q4 2021 Q2Q % growth | 312M 25.86% | 323.85M | -11.85M | -3.66% |
| Q3 2021 Q2Q % growth | 296M 14.51% | 303.75M | -7.75M | -2.55% |
| Q2 2021 Q2Q % growth | 288.9M -4.46% | 279M | 9.9M | 3.55% |
| Q1 2021 Q2Q % growth | 236.6M -0.21% | 255.65M | -19.05M | -7.45% |
| Q4 2020 Q2Q % growth | 247.9M 1.60% | 266.32M | -18.42M | -6.92% |
| Q3 2020 Q2Q % growth | 258.5M 16.39% | 288.7M | -30.2M | -10.46% |
| Q2 2020 Q2Q % growth | 302.4M 64.71% | 265.73M | 36.67M | 13.80% |
| Q1 2020 Q2Q % growth | 237.1M 71.32% | 228.35M | 8.75M | 3.83% |
| Q4 2019 Q2Q % growth | 244M 85.55% | 235.56M | 8.44M | 3.58% |
| Q3 2019 Q2Q % growth | 222.1M 46.31% | 215.86M | 6.24M | 2.89% |
| Q2 2019 Q2Q % growth | 183.6M 89.47% | 165.19M | 18.41M | 11.14% |
| Q1 2019 Q2Q % growth | 138.4M 94.66% | 139.77M | -1.37M | -0.98% |
| Q4 2018 Q2Q % growth | 131.5M | 134.23M | -2.73M | -2.03% |
| Q3 2018 Q2Q % growth | 151.8M | 150.91M | 890K | 0.59% |
| Q2 2018 Q2Q % growth | 96.9M | 85.458M | 11.442M | 13.39% |
| Q1 2018 Q2Q % growth | 71.1M | 64.31M | 6.79M | 10.56% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.46% | 26.77% | 0.23% | -12% |
| Revenue | 0.2% | 7.71% | 0.08% | 0.88% |